INDIANAPOLIS, May 2, 2016 /PRNewswire/ -- Eli Lilly and
Company (NYSE: LLY) today released its first-ever integrated
report, combining two of the company's traditional documents: its
annual report and its corporate responsibility report. Lilly's 2015
Integrated Report covers the company's business and financial
results along with progress on its broad-based social, employment,
and environmental activities. The new approach advances Lilly's
efforts to continually improve its corporate reporting and better
reflect the company's total impact on society.
In a video message to stakeholders, Lilly Chairman, President
and CEO John Lechleiter, Ph.D.,
said: "In 2015, we turned the corner in our business results and
began to grow again after a prolonged period of patent expirations.
At the same time, we made a great deal of progress in advancing our
pipeline of potential new medicines and demonstrated our ongoing
commitment to corporate responsibility. We continue to better align
our philanthropic goals with our fundamental business strategies
and, as a result, we're having greater impact."
Integrated Report Highlights
In 2015, despite unprecedented currency headwinds brought on by
the strengthening U.S. dollar, Lilly returned to revenue growth,
led by sales of existing products and several new product launches,
and significant contributions from the company's enlarged Elanco
animal health business.
Lilly achieved significant advances in its pipeline of molecules
in clinical development in 2015. As of early 2016, the company had
nine molecules in Phase III testing or regulatory review, including
potential medicines that hold the promise of advances in the
treatment of immunological disorders, Alzheimer's disease, and
various pain conditions.
On the corporate responsibility front, the company continued to
progress its global health work through the Lilly NCD Partnership
and the Lilly MDR-TB Partnership, which are focused on the growing
challenges of non-communicable diseases, such as diabetes, and
multidrug-resistant tuberculosis. Elanco continued to address the
key link between nutrition and health through its partnership with
Heifer International and through HATCH™ for Hunger, a community
partnership to provide eggs to undernourished people in the Midwest
region of the U.S.
Throughout 2015, Lilly employees extended the company's legacy
of volunteering and giving to strengthen communities around the
world. In the first five years of Lilly's Connecting Hearts Abroad
program, nearly 1,000 employees have worked a combined 64,000 hours
during two-week assignments in impoverished communities across
Africa, Asia, Eastern
Europe, and Latin America.
Additionally, Lilly employees worldwide have volunteered 825,000
hours since 2008 through the company's annual Global Day of
Service. And in 2015, Lilly and United Way advanced their nearly
100-year relationship through a new approach that paired 50 Lilly
teams with United Way agency partners with the goal of helping the
agencies advance their missions and serve more people.
Learn more in Lilly's 2015 Integrated Report, available on
www.lilly.com.
About Eli Lilly and Company
Lilly is a global
healthcare leader that unites caring with discovery to make life
better for people around the world. We were founded more than a
century ago by a man committed to creating high-quality medicines
that meet real needs, and today we remain true to that mission in
all our work. Across the globe, Lilly employees work to discover
and bring life-changing medicines to those who need them, improve
the understanding and management of disease, and give back to
communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at www.lilly.com and
newsroom.lilly.com/social-channels. C-LLY
Refer to: David Marbaugh; marbaugh@lilly.com;
317-489-7109
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lilly-releases-first-ever-integrated-report-300261040.html
SOURCE Eli Lilly and Company